A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting

PHASE2CompletedINTERVENTIONAL
Enrollment

701

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Postoperative Nausea and VomitingNausea and Vomiting, Postoperative
Interventions
DRUG

intravenous ondansetron

Trial Locations (58)

1020

GSK Investigational Site, Brussels

2143

GSK Investigational Site, Kistarcsa

2930

GSK Investigational Site, Braasschaat

3529

GSK Investigational Site, Miskolc

8001

GSK Investigational Site, Székesfehérvár

8903

GSK Investigational Site, New Brunswick

9023

GSK Investigational Site, Győr

9300

GSK Investigational Site, Aalst

10016

GSK Investigational Site, New York

10025

GSK Investigational Site, New York

11009

GSK Investigational Site, Cadiz

15213

GSK Investigational Site, Pittsburgh

15706

GSK Investigational Site, Santiago de Compostela

22601

GSK Investigational Site, Winchester

27103

GSK Investigational Site, Winston-Salem

28034

GSK Investigational Site, Madrid

29425

GSK Investigational Site, Charleston

30005

GSK Investigational Site, Alpharetta

30203

GSK Investigational Site, Cartagena

32504

GSK Investigational Site, Pensacola

34108

GSK Investigational Site, Naples

35043

GSK Investigational Site, Marburg

36106

GSK Investigational Site, Montgomery

39202

GSK Investigational Site, Jackson

52074

GSK Investigational Site, Aachen

56073

GSK Investigational Site, Koblenz

66160

GSK Investigational Site, Kansas City

67502

GSK Investigational Site, Hutchinson

70806

GSK Investigational Site, Baton Rouge

77024

GSK Investigational Site, Houston

77030

GSK Investigational Site, Houston

77054

GSK Investigational Site, Houston

78240

GSK Investigational Site, San Antonio

85032

GSK Investigational Site, Phoenix

91007

GSK Investigational Site, Arcadia

91010

GSK Investigational Site, Duarte

91109

GSK Investigational Site, Pasadena

91206

GSK Investigational Site, Glendale

92123

GSK Investigational Site, San Diego

92354

GSK Investigational Site, Loma Linda

92653

GSK Investigational Site, Laguna Hills

94305

GSK Investigational Site, Stanford

98801

GSK Investigational Site, Wenatchee

21229-5299

GSK Investigational Site, Baltimore

T2N 2T9

GSK Investigational Site, Calgary

T5H 3V9

GSK Investigational Site, Edmonton

V5Z 3C6

GSK Investigational Site, Vancouver

V6Z 1Y6

GSK Investigational Site, Vancouver

A1B 3V6

GSK Investigational Site, St. John's

B3K 6R8

GSK Investigational Site, Halifax

L8N 3Z5

GSK Investigational Site, Hamilton

N6A 4G5

GSK Investigational Site, London

N6A 4V2

GSK Investigational Site, London

M5T 2S8

GSK Investigational Site, Toronto

H3A 1A1

GSK Investigational Site, Montreal

G1L 3L5

GSK Investigational Site, Québec

J1H 5N4

GSK Investigational Site, Sherbrooke

G1V 4G2

GSK Investigational Site, Ste-Foy

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY